Skip to main content
. 2017 Aug;9(8):2587–2598. doi: 10.21037/jtd.2017.08.96

Table 4. Pathological diagnoses.

Diagnosisa All (N=196), n (%) NTUH (N=178), n (%) HGUA (N=18), n (%)
Primary lung cancerb 119 (60.7) 115 (64.6) 4 (22.2)
Adenocarcinoma 115 (58.7) 112 (62.9) 3 (16.6)
T1aN0M0 112 (57.1) 110 (61.7) 2 (11.1)
T1bN0M0c 1 (0.5) 0 1 (5.5)
T2N0M0 (PL1 or PL2)d 2 (1.0) 2 (1.1) 0
Squamous cell carcinoma 1 (0.5) 0 1 (5.5)
Carcinoid tumor 1 (0.5) 1 (0.5) 0
LELC 1 (0.5) 1 (0.5) 0
Tumorlet 1 (0.5) 1 (0.5) 0
Hodgkin lymphoma 1 (0.5) 1 (0.5) 0
Mucosa-associated lymphoid tissue (MALToma) 1 (0.5) 1 (0.5) 0
Metastatic lung cancer 22 (11.2) 20 (11.2) 2 (11.1)
Pleural metastasis 2 (1.0) 1 (0.5) 1 (5.5)
Adenocarcinoma in situ 9 (4.6) 9 (5.0) 0
Benign lesions 42 (21.4) 31 (17.4) 11 (61.1)

a, examination of 196 specimens in 188 patients; b, all primary lung cancers but 3 cases of adenocarcinoma belonged to T1aN0M0; c, in the T1b case: 3 cm tumor and lobectomy with lymphadenectomy was performed. d, in the 2 T2 cases: both lesions were less than 2 cm, but invaded visceral pleura. NTUH, National Taiwan University Hospital; HGUA, Hospital General Universitario Alicante; LELC, lymphoepithelioma-like carcinoma.